substance p has been researched along with Encephalopathy, Toxic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butt, MT; Higgins, D; Lappi, DA; Malkmus, SA; Osborn, KG; Rathbun, M; Richter, PJ; Russell, B; Steinauer, JJ; Veesart, SL; Wiese, AJ; Xu, Q; Yaksh, TL | 1 |
| Bacskai, T; Deak, A; Földes, I; Kelentey, B; Matesz, K; Veress, G; Zelles, T | 1 |
| Chan, YS; Chen, LW; Chu, JM; Yung, KK | 1 |
| Chapman, DE; Hanson, GR; Keefe, KA; Kesner, RP | 1 |
4 other study(ies) available for substance p and Encephalopathy, Toxic
| Article | Year |
|---|---|
Intrathecal substance P-saporin in the dog: distribution, safety, and spinal neurokinin-1 receptor ablation.
Topics: Animals; Behavior, Animal; Blood Pressure; Body Temperature; Body Weight; Dogs; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; In Situ Hybridization; Injections, Spinal; Neurokinin-1 Receptor Antagonists; Neurologic Examination; Neurotoxicity Syndromes; Ophthalmoscopy; Phenotype; Receptors, Neurokinin-1; Ribosome Inactivating Proteins, Type 1; Saporins; Spinal Cord; Substance P; Tissue Distribution | 2013 |
Modification of innervation pattern by fluoroquinolone treatment in the rat salivary glands.
Topics: Animals; Anti-Bacterial Agents; Calcitonin Gene-Related Peptide; Female; Immunohistochemistry; Injections, Intraperitoneal; Neurofilament Proteins; Neurotoxicity Syndromes; Organ Size; Parotid Gland; Pefloxacin; Peripheral Nervous System; Rats; Rats, Wistar; Sublingual Gland; Substance P | 2010 |
Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Topics: Analysis of Variance; Animals; Apomorphine; bcl-Associated Death Protein; Caspase 3; Cell Death; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; L-Lactate Dehydrogenase; Male; Motor Activity; Neuroblastoma; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Peptide Fragments; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Rotarod Performance Test; Signal Transduction; Substance P; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase | 2011 |
Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Topics: Animals; Basal Ganglia; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Electron Transport Complex IV; Gene Expression Regulation; In Situ Hybridization; Male; Methamphetamine; Neural Pathways; Neuropeptides; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Serial Learning; Substance P; Substantia Nigra | 2001 |